Browsing by Author Day, Richard O

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 43  next >
Issue DateTitleAuthor(s)Citation
2007Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolMcLachlan, Andrew; Stocker, Sophie; Day, Richard O; Graham, Garry G.; Hicks, Mark; Williams, Kenneth M.; Pharmacy; PharmacyClinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol, Clinical Pharmacokinetics, vol.46,(8),2007,pp 623-644
2005Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.Kerridge, Ian; Day, Richard O; Henderson, Kim M.; Henry, David A.; Hill, Suzanne R.; Macdonald, Graham J.; Maguire, Jane; McNeill, Paul M.; Newby, David A.; Stokes, Barrie J.; Central Clinical School: Ctr for Values Ethics & Law in MedCooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations., Internal Medicine Journal 2005, vol.35,(4),2005,pp 206-210
2006Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity.Gross, Annette; Loboz, Katarzyna; McLachlan, Andrew; Blievernicht, Julia; Day, Richard O; Liauw, Winston S.; Williams, Kenneth M.; Zanger, Ulrich M; Medicine Faculty Office; Pharmacy; PharmacyCytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity., Clinical Pharmacology & Therapeutics, vol.80,(1),2006,pp 75-84
2003Drug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines?Brien, Jo-anne; Tan, EE; Day, Richard O; Pharmacy; PharmacyDrug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines?, International Journal of Pharmacy Practice, vol.11,(3),2003,pp 175-181
2005Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsAmmit, Alaina; Duke, Colin; Jiang, Xuemin; McLachlan, Andrew; Roufogalis, Basil; Day, Richard O; Liauw, Winston S.; Williams, Kenneth M.; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyEffect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects, British Journal of Clinical Pharmacology, vol.59,(4),2005,pp 425-432
2004Effect Of St John's Wort And Ginseng On The Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsAmmit, Alaina; Duke, Colin; Jiang, Xuemin; McLachlan, Andrew; Roufogalis, Basil; Day, Richard O; Liauw, Winston S.; Williams, Kenneth M.; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyEffect Of St John's Wort And Ginseng On The Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects, British Journal of Clinical Pharmacology, vol.57,(5),2004,pp 592-599
2008Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazideMcLachlan, Andrew; Murray, Michael; Xu, Hongmei; Day, Richard O; Liauw, W.S.; Williams, K.M.; Pharmacy; Pharmacy; PharmacyEffects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide, British Journal of Pharmacology, vol.153,(7),2008,pp 1579-1586
2014Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trialLatimer, Jane; Lin, Chung-Wei Christine; Maher, Christopher; McLachlan, Andrew; Williams, Christopher; Day, Richard O; Hancock, Mark; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Pharmacy; The George Institute for Global HealthEfficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial, The Lancet, vol.384, 9954, 2014,pp 1586-1596
2014Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VIIKerridge, Ian; Lipworth, Wendy; Little, John Miles; Day, Richard O; Ghinea, N.; School of Public Health: Ctr for Values Ethics & Law in Med; School of Public Health: Ctr for Values Ethics & Law in Med; School of Public Health: Ctr for Values Ethics & Law in MedEthics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII, Hastings Center Report, vol.44, 2, 2014,pp 38-45
2012Evidence and desperation in off-label prescribing: recombinant factor VIIaKerridge, Ian; Lipworth, Wendy; Little, Miles (John); Day, Richard O; Central Clinical School: Ctr for Values Ethics & Law in Med; Central Clinical School: Ctr for Values Ethics & Law in Med; Central Clinical School: Ctr for Values Ethics & Law in MedEvidence and desperation in off-label prescribing: recombinant factor VIIa, BMJ (International Edition), vol.343, 7840, 2012,pp 1-3
2013Formulating an Ethics Agenda for Drug Development, Regulation, and UtilizationKerridge, Ian; Lipworth, Wendy; Day, Richard O; School of Public Health: Ctr for Values Ethics & Law in Med; School of Public Health: Ctr for Values Ethics & Law in MedFormulating an Ethics Agenda for Drug Development, Regulation, and Utilization, Therapeutic Innovation and Regulatory Science, vol.47, 1, 2013,pp 46-49
2012Fractional clearance of urate: Validation of measurement in spot-urine samples in healthy subjects and gouty patientsStocker, Sophie; Day, Richard O; Graham, Garry; Indraratna, Praveen L; Jones, Graham; Kannangara, Diluk R W; Portek, I.; Ramasamy, Sheena N; Williams, K.M.; PharmacyFractional clearance of urate: Validation of measurement in spot-urine samples in healthy subjects and gouty patients, Arthritis Research and Therapy, vol.14, 4, 2012,pp 1-8
2006Giving and receiving of gifts between pharmaceutical companies and medical specialists in AustraliaKerridge, Ian; Day, Richard O; Henderson, Kim M.; Henry, David A.; Hill, Suzanne R.; Macdonald, Graham J.; Maguire, Jane; McNeill, Paul M.; Newby, David A.; Stokes, Barrie J.; Central Clinical School: Ctr for Values Ethics & Law in MedGiving and receiving of gifts between pharmaceutical companies and medical specialists in Australia, Internal Medicine Journal (Print), vol.36,(9),2006,pp 571-578
2011How clinical and research failures lead to suboptimal prescribing: the example of chronic goutKerridge, Ian; Lipworth, Wendy; Brett, Jonathan; Day, Richard O; Central Clinical School: Ctr for Values Ethics & Law in Med; Central Clinical School: Ctr for Values Ethics & Law in MedHow clinical and research failures lead to suboptimal prescribing: the example of chronic gout, British Medical Journal, vol.343, 7835, 2011,pp d7459-1-d7459-3
2003Human subcutaneous tisue distribution of fluconazole: comparison of microdialysis and suction blister techniquesMcLachlan, Andrew; Sasongko, Lucy; Day, Richard O; Williams, Kenneth M.; Pharmacy; PharmacyHuman subcutaneous tisue distribution of fluconazole: comparison of microdialysis and suction blister techniques, British Journal of Clinical Pharmacology, vol.56,(5),2003,pp 551-561
2010Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteersStocker, Sophie; Day, Richard O; Graham, Garry G.; Ng, Daniel; Williams, Kenneth M.; PharmacyLack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers, European Journal of Clinical Pharmacology, vol.Online, N/A,pp 1-5
2005Manipulative therapy and/or NSAIDs for acute low back pain: design of a randomised controlled trial [ACTRN012605000036617].Cooper, Christopher; Hancock, Mark; Latimer, Jane; Maher, Christopher; McAuley, James; McLachlan, Andrew; Spindler, Megan; Day, Richard O; Central Clinical School: General Practice; Physiotherapy; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; Pharmacy; PharmacyManipulative therapy and/or NSAIDs for acute low back pain: design of a randomised controlled trial [ACTRN012605000036617]., BMC Musculoskeletal Disorders, vol.6,(57),2005,pp 1-6
2010Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometryMcLachlan, Andrew; Stocker, Sophie; Anderson, Jacqueline; Day, Richard O; Franklin, Michael; Pillans, Peter; Taylor, Paul; Williams, Kenneth M.; Pharmacy; PharmacyMeasurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol.878, N/A,pp 2363-2368
2005Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.Kerridge, Ian; Day, Richard O; Doran, Evan; Henderson, Kim M.; Henry, David A.; Hill, Suzanne R.; Macdonald, Graham J.; Maguire, Jane; McNeill, Paul M.; Newby, David A.; Stokes, Barrie J.; Central Clinical School: Ctr for Values Ethics & Law in MedMedical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience., Medical Journal of Australia, vol.182,(11),2005,pp 557-560
2011Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic?Chalmers, John; Kengne, Andre; Day, Richard O; Greenfield, Jerry R; Ho, Ken K Y; Lee, P.; The George Institute for International Health; The George Institute for International HealthMetabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic?, International Journal of Obesity, vol.35, 11, 2011,pp 1395-1403